Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab

Figure 2

Copy number profile of non-small-cell lung cancer tumor sample identifies ERBB2 amplification as a potentially actionable alteration. A tumor sample from the patient’s lung was used to perform comprehensive genomic profiling. The resulting copy number profile is shown, with observed copy numbers being displayed on the -axis. The red circle indicates the amplification of a genomic region that includes the ERBB2 gene.